Home › NDC Lookup › RxCUI directory › RxCUI 248834

Methylene blue 10 MG/ML Oral Solution — RxCUI 248834

RxNorm drug concept · Semantic clinical drug
RxCUI 248834 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI248834
Official nameMethylene blue 10 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethylene blue 1 % Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylene Blue: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats acquired methemoglobinemia, a condition where your blood can't carry oxygen well. It's used in both adults and children. It's given in a medical setting, so your care tea...
  • What is methylene blue injection used for?
  • It's given slowly into a vein, usually over 5 to 30 minutes. A second dose may be given an hour later if needed. It must never be injected under the skin.
  • This is the big one. Methylene blue can cause serious or even fatal serotonin syndrome when combined with SSRIs, SNRIs, MAOIs, opioids and some other drugs. Tell your care team abo...
📖 Read our full Methylene Blue guide →

🕸️ Concept Web — How Methylene blue 10 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methylene blue 10 MG/ML Oral Solution RxCUI 248834

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methylene blue 6878
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylene blue Oral Solution 385008
    • Methylene blue Oral Liquid Product 1162881
    • Methylene blue Oral Product 1162882
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Methylene blue 10 MG/ML 384813

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methylene blue 10 MG/ML SCDC · 384813
  • Methylene blue Oral Solution SCDF · 385008
  • Methylene blue Oral Liquid Product SCDG · 1162881
  • Methylene blue Oral Product SCDG · 1162882

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 248834 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
86241-0003-09 50 mL in 1 BOTTLE (86241-003-09) Ozipco 1% METHYLENE BLUE Fast Sold LLC 2025-01-10
Observed labelers: Fast Sold LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.